NEWS

Feel the vibe of LINNC Asia seminar 2018!

DCB angioplasty for MCA stenosis

Foramen magnum dural AVF

Cerenovus launches largest global registry to study stroke-inducing bloo...

Company Also Receives European CE Mark Approval for Novel Stroke Technology Designed for Difficult to Extract Blood ClotsIRVINE, Calif., Dec. 10, 2018 -- Johnson & Johnson Medical Devices Companies* today announced that its CERENOVUS business has launched the single largest global registry, the EXCELLENT Registry, to collect and analyze stroke-inducing blood clots removed from the brain with its EMBOTRAP II Revascularization Device, a next generation stent retriever used in mechanical thrombectomy.

Pediatric giant basilar top aneursym

3rd regional course in diag. and treatment of ICH

Don't miss the best of LINNC Asia 2018

AVM treated with PHIL

Chasing sunshine at LINNC Americas Miami 2019!

Bi-lobulated ACA aneurysm simulation treatment